The Pennant Group (NASDAQ:PNTG – Get Free Report) is one of 233 publicly-traded companies in the “Healthcare Providers & Services” industry, but how does it contrast to its peers? We will compare The Pennant Group to related companies based on the strength of its valuation, dividends, analyst recommendations, risk, earnings, institutional ownership and profitability.
Valuation & Earnings
This table compares The Pennant Group and its peers revenue, earnings per share and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| The Pennant Group | $947.71 million | $29.58 million | 36.90 |
| The Pennant Group Competitors | $21.44 billion | $301.67 million | 6.82 |
The Pennant Group’s peers have higher revenue and earnings than The Pennant Group. The Pennant Group is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.
Profitability
This table compares The Pennant Group and its peers’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| The Pennant Group | 3.05% | 10.23% | 4.06% |
| The Pennant Group Competitors | -8.06% | -138.13% | -1.54% |
Volatility and Risk
The Pennant Group has a beta of 1.33, meaning that its stock price is 33% more volatile than the S&P 500. Comparatively, The Pennant Group’s peers have a beta of 0.98, meaning that their average stock price is 2% less volatile than the S&P 500.
Analyst Ratings
This is a breakdown of recent recommendations for The Pennant Group and its peers, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| The Pennant Group | 0 | 1 | 6 | 0 | 2.86 |
| The Pennant Group Competitors | 1867 | 7737 | 13362 | 823 | 2.55 |
The Pennant Group presently has a consensus price target of $48.00, indicating a potential upside of 31.40%. As a group, “Healthcare Providers & Services” companies have a potential upside of 13.63%. Given The Pennant Group’s stronger consensus rating and higher probable upside, research analysts clearly believe The Pennant Group is more favorable than its peers.
Insider & Institutional Ownership
85.9% of The Pennant Group shares are held by institutional investors. Comparatively, 56.7% of shares of all “Healthcare Providers & Services” companies are held by institutional investors. 6.9% of The Pennant Group shares are held by company insiders. Comparatively, 15.0% of shares of all “Healthcare Providers & Services” companies are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Summary
The Pennant Group beats its peers on 9 of the 13 factors compared.
About The Pennant Group
The Pennant Group, Inc. provides healthcare and senior living services through independently operated subsidiaries. Its services include home health and hospice care for people in their homes, as well as senior living options such as assisted living and memory care. Based in Eagle, Idaho, the company operates across multiple U.S. states, with a presence concentrated in the western part of the country. Its local operating teams provide care and support to patients, residents and their families. Pennant became an independent publicly traded company in 2019 after separating from The Ensign Group.
Receive News & Ratings for The Pennant Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Pennant Group and related companies with MarketBeat.com's FREE daily email newsletter.
